Lung inflammation postoperative prediction system based on mycoplasma pneumoniae infection
By developing a postoperative prediction system for mycoplasma pneumoniae infected lung inflammation that includes data collection, feature extraction, data fusion, prognosis prediction and data visualization modules, the problem of data being difficult to present in the prior art is solved, and the accuracy and personalization of postoperative prognosis evaluation are improved.
Patent Information
- Application Number
- CN202411927748.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-12-25
- Publication Date
- 2025-04-18
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The prior art is difficult to present clinical data, imaging data and biomarker data after multi-dimensional and complex lung inflammation infected by Mycoplasma pneumoniae to clinicians in an intuitive and easy-to-understand way, affecting the timeliness and accuracy of decision-making.
A postoperative prediction system for lung inflammation based on Mycoplasma pneumoniae infection is developed, including a data acquisition module, a feature extraction and processing module, a multi-dimensional data fusion module, a prognosis prediction module and a data visualization module. A machine learning algorithm is used to fuse multi-dimensional data to build a postoperative prognosis evaluation model, and present the prediction results in the form of charts and curves.
It improves the accuracy and personalization of postoperative prognosis assessment, helping clinicians to more intuitively understand the patient's condition and prognosis, and make timely and accurate decisions.